This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
ADSCaN: a randomised phase II study of accelerated, dose escalated, sequential chemo radiotherapy in non-small cell lung cancer (NSCLC). (January 2020)
Record Type:
Journal Article
Title:
ADSCaN: a randomised phase II study of accelerated, dose escalated, sequential chemo radiotherapy in non-small cell lung cancer (NSCLC). (January 2020)
Main Title:
ADSCaN: a randomised phase II study of accelerated, dose escalated, sequential chemo radiotherapy in non-small cell lung cancer (NSCLC)